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SEV-ERAL authors have described how
measurements of cell surviving fraction
following bleomycin (BLM) treatment of
a solid mouse tumour (Hahn et al., 1973;
Twentyman and Bleehen, 1974, 1975) or a
mouse ascites tumour (Takabe et al.,
1974) are extremelv dependent upon the
time after treatment at which the assay is
performed. Suirviving fractions measured
within 2 h of drug treatment are much
lower than those observed following a
delay of 6-24 h. The experiments described
here indicate that an artefact is involved
and that surviving fractions measured
soon after BLM treatment are likely to be
falsely low.
The EMT6 tumour and the method of
handling as used in our laboratory have
been previously described (Rockwell, Kall-
man & Farjardo, 1972; Twentyman and
Bleehen, 1974, 1975). Briefly, 105 cells
taken from culture were inoculated into
the flanks of male BALB/C mice and a
solid tumour grew to a size of100-200 mm3
between Days 10 and 13. Bleomycin
(kindlv supplied by Lundbeck Ltd) was
injected i.p. into tumour-bearing mice, and
cell suspensions prepared from their
tumours at various times afterwards.
In the present series of experiments,
cells from untreated tumours were exposed
to BLM either (a) for a period of 20 min
during the makiing of the single cell
suspension, or (b) for 20 min immediatelv
following resuspension of the cell pellet.
In (a), BLAI at the appropriate con-
centrations was added to various aliquots
Accepted 22 Jtune 1977
of trypsinized Hanks' solution. Following
removal from the mouse, an untreated
tumour was cut into 4 equal parts, and
each part was made into a separate cell
suspension using aliquot,s of trypsinized
Hanks' solution with different concentra-
tions of added BLM. At the end of this
period, filtration was carried out as usual,
and each suspension washed and centri-
fuged twice in complete medium before
counting and plating. In (b), a suspension
was made from a complete, untreated
tumour as usual. Samples of the prepared
suspension were then spun down and the
cells resuspended in complete medium
containing various concentrations of BLM
at 37°C. The suspensions were then gently
agitated for 20 min on a magnetic stirrer
at room temperature. At the end of this
time, the cells were twice spun down and
resuspended in complete medium before
counting and plating.
In the second group of experiments, a
treated tumour and an untreated tumour
of similar size were each removed from
individual mice and cut into halves. Three
separate suspensions were then made, one
from half of the untreated tumour ( ),
one from half of the treated tumour ( + ),
and one from half of each tumour added
together (0).
Processing of the suspensions, including
counting, diluting and plating was carried
out in the usual way. In order to study
possible effects of trypsin and/or Hanks'
solution upon the sensitivity to BLM, this
type of experiment was also carried outARTEFACT IN BLEOMYCIN ASSAYS
(a) with the omission of trypsin from the
Hanks' solution and (b) using complete
medium instead of trypsinized Hanks'
solution for making the suspensions.
Similar experiments were also carried
out in which the treated mouse had
received (i) 3200 rad of 240 kV X-irradia-
tion to the tumour immediately before
preparation of the cell suspensions. (ii)
200 mg/kg of cyclophosphamide i.p. 2 h
before preparation of the cell suspension.
(iii) 20 mg/kg of BCNU i.p. 2 h before
preparation of the cell suspension.
RESULTS
The results of exposing cells to BLM in
vitro either during or after the making of
the cell suspension are shown in the Fig.
It may be seen that the sensitivity is about
3 orders of magnitude greater during the
making of the suspension than imme-
diately after resuspension. Similar results
were obtained in a repeat of this experi-
ment.
The results of experiments in which
untreated and BLM treated tumours
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were divided into halves and 3 suspensions
made are shown in Table I. In each case,
the cell yield from the treated and
untreated tumour halves was similar,
hence in the third suspension (0) half of
the total number of cells would have come
from each of the 2 tumour halves. It is
seen that, in each experiment, the number
of colonies produced by Suspension 0 was
much lower thanwouldhavebeenexpected
from the colony-forming ability of the
individual halves. If, however, cells from
the 2 separate suspensions ( - and + )
were plated into the same dish, no inter-
action was seen, and the colony count was
merely the sum ofthe counts produced by
the individual suspensions.
These experiments were repeated with
(a) the omission of trypsin from the
Hanks' solution and (b) using complete
medium instead of trypsinized Hanks'
solution for making the suspensions. In
both these cases, there was considerably
more cell debris present in the suspensions
produced, and the plating efficiencies were
lower. The results, however, were in each
case very similar to those shown in Table I.
Experiments combining tumour halves
in which the treated tumour had received
either X-rays, cyclophosphamide orBCNU
are shown in Table II. In each of these
experiments, and in similar repeats, there
was no interaction between the colony
formation of the tumour halves as has
been described for BLM.
DISCUSSION
The results presented here show that,
for BLM, but not for any of the other
agents studied, drug carry-over presents
a problem in measuring surviving fraction
at early times after drug administration
in vivo. Drug carried over by tumours
from BLM-treated animals into the sus-
pension vessel is able to kill cells from
untreated tumours in the same vessel.
There is no reason to think that cells from
the tumour which did the carrying-over
are not killed to at least the same extent
as are cells from the untreated tumour.
In the light of these results, it would
appear that the observed rapid change in
measured surviving fraction following
BLM treatment in vivo of the EMT6
tumour (Hahnet al., 1973; Twentymanand
Bleehen, 1974, 1975) can be explained
without recourse to the phenomenon of
''recovery from potentially lethal
damage". However, in other circum-
stances where an unexplained change in
measured surviving fraction occurs (i.e.
following X-irradiation (Little et al., 1973),
cyclophosphamide (Hahn et al., 1973;
Twentyman, 1977), or BCNU (Twenty-
man, in preparation), the artefact de-
scribed here does not appear to operate.
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